Xinjie Chen Selected Research

Albumin-Bound Paclitaxel

2/2021

Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer: A protocol for systemic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinjie Chen Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 10/2008
4	Esophageal Squamous Cell Carcinoma 10/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2021
3	Melanoma (Melanoma, Malignant) 11/2022 - 04/2022
2	Inflammation (Inflammations) 01/2024 - 01/2021
2	Neuroinflammatory Diseases 01/2024 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 06/2019
2	Esophageal Neoplasms (Esophageal Cancer) 10/2023 - 01/2020
2	Thalassemia 01/2012 - 11/2011
1	Infections 01/2024
1	Multiple Sclerosis 01/2024
1	COVID-19 01/2024
1	Vesicular Stomatitis 10/2023
1	Lung Neoplasms (Lung Cancer) 11/2022
1	Stomach Neoplasms (Stomach Cancer) 11/2022
1	Osteonecrosis (Kienbock's Disease) 04/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Infarction (Infarctions) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Dysbiosis 01/2022
1	Mycoses (Diseases, Fungus) 01/2021
1	Osteoarthritis 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Abscess 01/2021
1	Cerebral Hemorrhage 11/2019
1	Leukemia 06/2019
1	1.35-Mb Chromosome 1q21.1 Deletion Syndrome 04/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012

Drug/Important Bio-Agent (IBA)

3	NanovaccinesIBA 11/2022 - 04/2022
2	CytokinesIBA 01/2024 - 10/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2008
2	EnzymesIBA 01/2023 - 01/2023
2	VaccinesIBA 11/2022 - 04/2022
2	Peptides (Polypeptides)IBA 11/2022 - 11/2022
2	MagnesiumIBA 11/2022 - 11/2022
2	AntigensIBA 11/2022 - 10/2008
2	MicroRNAs (MicroRNA)IBA 04/2022 - 11/2019
2	Messenger RNA (mRNA)IBA 04/2015 - 10/2008
1	Carisoprodol (Soma)FDA LinkGeneric 01/2024
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	Collagen Type I (Type I Collagen)IBA 10/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	CollagenIBA 10/2023
1	Histocompatibility Antigens Class IIBA 10/2023
1	Small Interfering RNA (siRNA)IBA 10/2023
1	I-antigenIBA 10/2023
1	Glycoproteins (Glycoprotein)IBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	magnetoferritinIBA 01/2023
1	Arsenic Trioxide (Trisenox)FDA Link 01/2023
1	Drug CarriersIBA 01/2023
1	Glucose OxidaseIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	EpitopesIBA 11/2022
1	Imiquimod (Aldara)FDA LinkGeneric 11/2022
1	Cancer VaccinesIBA 11/2022
1	Antineoplastic Agents (Antineoplastics)IBA 11/2022
1	auristatinIBA 11/2022
1	Thrombin FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	PropionatesIBA 01/2022
1	CholesterolIBA 01/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	GadoliniumIBA 01/2022
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2022
1	SolventsIBA 02/2021
1	Albumin-Bound Paclitaxel FDA Link 02/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2021
1	GelatinIBA 01/2021
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2021
1	oridoninIBA 06/2019
1	HomoharringtonineIBA 06/2019
1	Glia Maturation Factor (GMF)IBA 01/2018
1	Cre recombinaseIBA 01/2012
1	Doxycycline (Periostat)FDA LinkGeneric 01/2012
1	Histone Deacetylase InhibitorsIBA 11/2011
1	theasinensin AIBA 11/2011

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2012
4	Radiotherapy 10/2023 - 01/2020
3	Drug Therapy (Chemotherapy) 11/2022 - 02/2021
2	Immunotherapy 10/2023 - 11/2022
2	Lasers (Laser) 01/2023 - 01/2021
2	Chemoradiotherapy 11/2022 - 01/2022
1	Intravenous Administration 10/2023
1	Subcutaneous Injections 11/2022
1	Neoadjuvant Therapy 01/2020
1	Adjuvant Radiotherapy 01/2020